By a-CGH analysis on tumor DNA at progression, we found the loss 12p13.31, containing KLRB1 gene, the loss 16p11.2 containing MAPK3 gene, and the loss 16q11.2–q24.3, containing FANCA gene. The gene discussed is MAPK3; the disease is neoplasm.